Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

Rhea-AI Summary

Clarivate (NYSE:CLVT) has renewed and expanded its partnership with CAPES, Brazil's key education agency, in a landmark five-year agreement. The collaboration extends access to critical research tools and data across over 400 Brazilian institutions, marking a 57% increase in institutional coverage. The partnership provides access to essential platforms including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence, and Derwent Innovation Index. This expansion particularly benefits institutions in remote regions, supporting CAPES' mission to reduce regional disparities in academic research. The agreement builds on a relationship that began in 2001, empowering researchers, scholars, and healthcare professionals with comprehensive data access. Brazil's research output shows strong international collaboration, with 40% of output being internationally collaborative and demonstrating above-average impact in medicine and significant focus on Life Sciences and Sustainable Development Goals.

Positive

• 57% increase in institutional coverage, expanding access to over 400 Brazilian institutions
• Provides access to critical research tools including Web of Science and Cortellis Drug Discovery Intelligence
• Supports reduction of regional research disparities by including remote institutions
• Strong international research collaboration with 40% of output being internationally collaborative
• Above average impact in medicine research (1.1 times world average)

Negative

• None.

Insights

Business Intelligence Analyst

Clarivate's expanded 5-year CAPES partnership brings stable recurring revenue while strengthening market position in Brazil's growing research sector.

Clarivate's renewed partnership with CAPES represents a strategic expansion in the Brazilian academic market that should positively impact the company's long-term revenue stability. The five-year agreement increases institutional coverage by 57%, extending Clarivate's products to over 400 Brazilian institutions, creating a substantially enlarged user base for their Academia & Government and Life Sciences & Healthcare solutions.

This deal builds upon a 23-year relationship that began in 2001, demonstrating Clarivate's ability to maintain and expand key institutional partnerships. The breadth of tools provided - Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence, and Derwent Innovation Index - showcases Clarivate's comprehensive portfolio penetration rather than just single-product adoption.

From a business perspective, this expansion aligns perfectly with Clarivate's strategic focus on recurring revenue streams through multi-year contracts with large institutional clients. The geographic diversification into emerging markets like Brazil reduces Clarivate's dependence on mature markets while positioning them in regions with growing research output. Brazil's research landscape shows promising metrics: 40% international collaboration, strong life sciences focus, and above-average impact in medical research.

The deal's emphasis on expanding access beyond major urban centers to remote regions demonstrates potential for further penetration into previously underserved markets. This aligns with CAPES' mission to democratize research access and reduce regional disparities, potentially creating a replicable model for similar partnerships in other emerging markets with similar geographic challenges.

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence

LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions.

As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to  solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index.

By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines.

Matti Shem Tov, Chief Executive Officer, Clarivate, said: "This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond."

Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference."

The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement.

Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas.

By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research.

Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights.

To learn more about this partnership and the solutions now available to CAPES institutions, visit here.

Notes to editors

According to the most recent Institute for Scientific Information G20 research and innovation scorecard:

• Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact.
• Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average.
• More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average.
• Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average.

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields.

Media contacts: 

Clarivate

Rebecca Krahenbuhl
Senior Manager, External Communications – Academia & Government
newsroom@clarivate.com

Catherine Daniel
Director, External Communications – Life Sciences & Healthcare
newsroom@clarivate.com

CAPES
João Mendes
Communications
joao.mendes@capes.gov.br  

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-and-capes-expand-landmark-partnership-to-power-research-and-innovation-across-brazil-302469715.html

SOURCE Clarivate Plc

FAQ

What is the duration and scope of Clarivate's new partnership with CAPES?

The partnership is a five-year agreement that provides access to research tools across over 400 Brazilian institutions, representing a 57% increase in institutional coverage.

What research tools are included in the CLVT-CAPES partnership?

The partnership includes access to Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence, and Derwent Innovation Index.

How does this partnership benefit Brazilian research institutions?

It provides broader access to research tools across Brazil, particularly benefiting remote institutions, and supports reducing regional disparities in academic research capabilities.

What are Brazil's current research strengths according to the Institute for Scientific Information?

Brazil shows strong international collaboration (40% of output), above-average impact in medicine, focus on Life Sciences, and significant research in Sustainable Development Goals.

When did the partnership between Clarivate and CAPES begin?

The partnership began in 2001 when Web of Science became one of the first databases integrated into the CAPES Portal.